These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17443493)

  • 1. Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models.
    Määttä AM; Liimatainen T; Wahlfors T; Wirth T; Vähä-Koskela M; Jansson L; Valonen P; Häkkinen K; Rautsi O; Pellinen R; Mäkinen K; Hakumäki J; Hinkkanen A; Wahlfors J
    Int J Cancer; 2007 Aug; 121(4):863-70. PubMed ID: 17443493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.
    Määttä AM; Mäkinen K; Ketola A; Liimatainen T; Yongabi FN; Vähä-Koskela M; Pirinen R; Rautsi O; Pellinen R; Hinkkanen A; Wahlfors J
    Int J Cancer; 2008 Oct; 123(7):1704-11. PubMed ID: 18651570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
    Ketola A; Hinkkanen A; Yongabi F; Furu P; Määttä AM; Liimatainen T; Pirinen R; Björn M; Hakkarainen T; Mäkinen K; Wahlfors J; Pellinen R
    Cancer Res; 2008 Oct; 68(20):8342-50. PubMed ID: 18922906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked enhancement of antitumor immune responses in mouse brain tumor models by genetically modified dendritic cells producing Semliki Forest virus-mediated interleukin-12.
    Yamanaka R; Zullo SA; Ramsey J; Yajima N; Tsuchiya N; Tanaka R; Blaese M; Xanthopoulos KG
    J Neurosurg; 2002 Sep; 97(3):611-8. PubMed ID: 12296646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles.
    Murphy AM; Morris-Downes MM; Sheahan BJ; Atkins GJ
    Gene Ther; 2000 Sep; 7(17):1477-82. PubMed ID: 11001367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.
    Yamanaka R; Zullo SA; Tanaka R; Blaese M; Xanthopoulos KG
    J Neurosurg; 2001 Mar; 94(3):474-81. PubMed ID: 11235953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice.
    Martikainen M; Ruotsalainen J; Tuomela J; Härkönen P; Essand M; Heikkilä J; Hinkkanen A
    Br J Cancer; 2017 Jun; 117(1):51-55. PubMed ID: 28557974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semliki Forest virus-mediated gene therapy of the RG2 rat glioma.
    Roche FP; Sheahan BJ; O'Mara SM; Atkins GJ
    Neuropathol Appl Neurobiol; 2010 Dec; 36(7):648-60. PubMed ID: 20649937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade.
    Quetglas JI; Labiano S; Aznar MÁ; Bolaños E; Azpilikueta A; Rodriguez I; Casales E; Sánchez-Paulete AR; Segura V; Smerdou C; Melero I
    Cancer Immunol Res; 2015 May; 3(5):449-54. PubMed ID: 25691326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
    Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
    Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus.
    Vähä-Koskela MJ; Tuittila MT; Nygårdas PT; Nyman JK; Ehrengruber MU; Renggli M; Hinkkanen AE
    J Neurovirol; 2003 Feb; 9(1):1-15. PubMed ID: 12587064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.
    Kramer MG; Masner M; Casales E; Moreno M; Smerdou C; Chabalgoity JA
    BMC Cancer; 2015 Sep; 15():620. PubMed ID: 26347489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Semliki forest virus vector engineered to express IFNα induces efficient elimination of established tumors.
    Quetglas JI; Fioravanti J; Ardaiz N; Medina-Echeverz J; Baraibar I; Prieto J; Smerdou C; Berraondo P
    Gene Ther; 2012 Mar; 19(3):271-8. PubMed ID: 21734727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12.
    Yamanaka R; Tsuchiya N; Yajima N; Honma J; Hasegawa H; Tanaka R; Ramsey J; Blaese RM; Xanthopoulos KG
    J Neurosurg; 2003 Oct; 99(4):746-53. PubMed ID: 14567611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semliki Forest virus A7(74) transduces hippocampal neurons and glial cells in a temperature-dependent dual manner.
    Ehrengruber MU; Renggli M; Raineteau O; Hennou S; Vähä-Koskela MJ; Hinkkanen AE; Lundstrom K
    J Neurovirol; 2003 Feb; 9(1):16-28. PubMed ID: 12587065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of a therapeutic antitumor immunological response by intratumoral injection of genetically engineered Semliki Forest virus to produce interleukin-12.
    Yamanaka R; Zullo SA; Tanaka R; Ramsey J; Blaese M; Xanthopoulos KG
    Neurosurg Focus; 2000 Dec; 9(6):e7. PubMed ID: 16817690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semliki forest virus vectors engineered to express higher IL-12 levels induce efficient elimination of murine colon adenocarcinomas.
    Rodriguez-Madoz JR; Prieto J; Smerdou C
    Mol Ther; 2005 Jul; 12(1):153-63. PubMed ID: 15963931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.